Antiretroviral Treatment for Adult HIV Infection in 2002

2002713 citationsReview

Authors

Patrick Yéni · Université Claude Bernard Lyon 1

Scott M. Hammer · Université Paris Cité

Charles C. J. Carpenter · Université Paris Cité

David A. Cooper · Université Paris Cité

Margaret A. Fischl · Université Paris Cité

José M. Gatell · Université Paris Cité

Brian Gazzard ·

Abstract

Because of increased awareness of the activity and toxicity of current drugs, the threshold for initiation of therapy has shifted to a later time in the course of HIV disease. However, the optimal time to initiate therapy remains imprecisely defined. Availability of new drugs has broadened options for therapy initiation and management of treatment failure, which remains a difficult challenge.

Topics & Keywords

HIV/AIDS Research and Interventions HIV/AIDS drug development and treatment HIV-related health complications and treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 288, Issue 2, pp. 222-222

DOI: 10.1001/jama.288.2.222

Field-Weighted Citation Impact: 71.96